A benefit-cost analysis of two-dose measles immunization in Canada

Vaccine

Volumn 16, Issue 9-10, 1998, Pages 989-996

  Pelletier, Louise ^a,c   Chung, Patricia ^b   Duclos, Philippe ^a   Manga, Pran ^b   Scott, Jeff ^b  

^a LAB CENTRE FOR DISEASE CONTROL   (Canada)

^b Pran Manga and Associates   (Canada)

^c Tuberculosis Prevention and Control   (Canada)

Author keywords

Analysis; Cost; Measles

Indexed keywords

MEASLES VACCINE;

ADOLESCENT; ADULT; ARTICLE; CANADA; COST BENEFIT ANALYSIS; HUMAN; INTERMETHOD COMPARISON; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; MUMPS; PRESCHOOL CHILD; PRIORITY JOURNAL; RUBELLA; SCHOOL CHILD; TREATMENT PLANNING;

ADOLESCENT; AGE FACTORS; CANADA; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DISEASE OUTBREAKS; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MEASLES; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; MUMPS VACCINE; RUBELLA; RUBELLA SYNDROME, CONGENITAL; RUBELLA VACCINE; SENSITIVITY AND SPECIFICITY; VACCINES, COMBINED;

EID: 0032077084     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00281-8     Document Type: Article

References (24)

1. 1 Acres, R. and Varughese, P. Impact of vaccination on selected diseases in Canada. Can. Med. Assoc. J. 1985, 132, 535-639.
2. 2 LCDC. Notifiable diseases annual summary, 1994. Can. Commun. Dis. Rep. 1996, 22S2, 76-77.
3. 3 Gustafson, T.L., Lievens, A.W., Brunell, P.A., Moellenberg, R.G., Buttery, C.M. and Jehulster, L.M. Measles outbreak in a fully immunized secondary-school population. N. Engl. J. Med. 1987, 316, 771-774.
4. 4 Nkowane, B.M., Bart, S.W., Oreinstein, W.A. and Baltier, N. Measles outbreak in a vaccinated school population: epidemiology, chains of transmission and the role of vaccine failures. Am. J. Public Health 1987, 77, 434-438.
5. 5 LCDC. Consensus conference on measles. Can. Commun. Dis. Rep. 1993, 19, 72-79.
6. 6 LCDC. Supplementary statement on measles elimination in Canada. Can. Commun. Dis. Rep. 1996, 22, 9-15.
7. 7 Hatziandreu, E.A., Brown, R.E. and Halpers, M.T. A Cost-Benefit Analysis of Measles-Mumps-Rubella (MMR) Vaccine. Battelle, Arlington, 1994.
8. 8 Plotkin, S.A. and Mortimer, E.A. Vaccines. 2nd ed. Saunders, Philadelphia, 1994.
9. 9 Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. CDC, Atlanta, January 1995.
10. 10 Feigin, R.D. and Cherry, J.D. Textbook of Pediatric Infectious Diseases. 3rd ed., Vol. II. Saunders, Philadelphia, 1992.
11. 11 Mandell, G.L., Bennett, J.E. and Dolin, R. Principles and Practice of Infectious Diseases. 4th ed. Churchill Livingstone, New York, 1995.
12. 12 Centers for Disease Control. Mumps Surveillance, January 1977-December 1982. CDC, Atlanta, September 1984.
13. 13 Statistics Canada. Earnings of men and women in 1993, Catalogue No. 13-217, 1995.
14. 14 Statistics Canada. Labour force annual averages 1989-94, Catalogue No. 77-529, 1995.
15. 15 Congenital rubella - 50 years on 1991. Lancet, 1991, 337, 668.
16. 16 Kaplan, K.M., Marder, D.C., Cochi, S.L. and Preblud, S.R. Mumps in the workplace: further evidence of the changing epidemiology of a childhood vaccine-preventable disease. JAMA 1988, 260, 1434-1438.
17. 17 Davis, R.M., Markowitz, L.E., Preblud, S.R., Orenstein, W.A. and Hinman, A.R. A cost-effectiveness analysis of measles outbreaks control strategies. Am. J. Epidemiol. 1987, 126, 450-459.
18. 18 Atkinson, W.L. and Orenstein, W.A. The resurgence of measles in the United States, 1989-1990. Annu. Rev. Med. 1992, 43, 451-463.
19. 19 Daniels, S. and Naus, M. Surveys of vaccine storage and handling in Ontario, PHERO 01/28/94, 2-9.
20. 20 National Advisory Committee on Immunization. Canadian Immunization Guide. 4th ed. Ottawa, Health Canada, 1993.
21. 21 Institute of Medicine. Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines. Adverse Effects of Pertussis and Rubella Vaccines. National Academy Press, Washington.
22. 22 Institute of Medicine. Vaccine Safety committee. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Casuality. National Academy Press, Washington, 1994.
23. 23 Ginsberg, G.M. and Tulchinsky T.T. Costs and benefits of a second measles inoculation of children in Israel, the West Bank and Gaza. J. Epidemiol. Commun. Hlth 1990, 44, 274-280.
24. 24 Gay, N.J., Pelletier, L. and Duclos, P. Modelling the incidence of measles in Canada: an assessment of the options for vaccination policy Vaccine 1998, 16, 794-801.